Drug Delivery Markets, Vol II: Implantable Injectable

Table of Contents

Chapter one: Executive Summary

• Market Drivers
• Market Size and Growth
  • Total Injectable/Implantable Drug Delivery Market
  • The Injectable/Implantable Drug Delivery Only Market
• Competitor and Market Analysis

Chapter two: Introduction

• Scope and Methodology
• Reasons for Injectable/Implantable Drug Delivery Systems
• History of Injectable/Implantable Drug Delivery
• Phases of Drug Action
• Needle-Free Drug Delivery
  • Major Applications
  • Safety Concerns
  • Products
• Implantable Drug Delivery
  • Mechanisms
  • Applications
  • Products
• Sustained-Release Drug Delivery
  • Products
• Targeted Injection Drug Delivery
  • Products

Chapter three: Trends and Developments

• Drivers of the Injectable/Implantable Drug Delivery Market
  • Biologics
  • Cancer
• Pen injectors
• Proprietary Product Development
• Delivery Systems Placement Trends
• Therapeutic Trends
• Incorporation of Technology
• Nanotechnology
• Drug Delivery Development
  • Microsphere Technology
  • Targeted Technology
  • MicroChip Technology
  • NanoParticles
  • Protein-Coated Microcrystal Technology
  • Needle-Free Delivery Development
  • Selected Products in Development

Chapter four: Market Size and Growth

• The Total Injectable/Implantable Drug Delivery Market
• Injectable/Implantable Delivery Technology Only Market

chapter five: Competitive and Market Analysis

• Competitive Landscape
• Market Analysis

Chapter six: Company Profiles

• Alkermes, Inc.
• ALZA Corp.
• Antares Pharma, Inc.
• Bioject Medical Technologies, Inc.
• CyDex, Inc.
• MGI Pharma, Inc
• Nektar Therapeutics
• PowderMed Pharmaceuticals Plc
• SkyePharma Plc
• Zogenix Corporation

Chapter seven: Companies in Brief

• AP Pharma
• Baxter BioPharma Solutions
• ImaRx Therapeutics Inc.
• PR Pharmaceuticals, Inc.
• pSivida
• QLT USA, Inc

Appendix: Company Directory

TABLE OF EXHIBITS

Chapter one: Executive Summary

• Figure 1-1: The Worldwide Market for Injectable/Implantable
• Drug Delivery Technology and Pharmaceuticals 2002-2010

Chapter two: Introduction

• Table 2-1: Sequence of Drug Action

Chapter three: Trends and Developments

• Table 3-1: Select Products in Early Stage Development by Drug
• Delivery Companies

Chapter four: Market Size and Growth

• Table 4-1: Worldwide Market for Injectable/Implantable Drug Delivery Technology and Pharmaceuticals 2002-2010
• Figure 4-1: Worldwide Market for Injectable/Implantable Drug Delivery Technology and Pharmaceuticals 2002-2010
• Table 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery by Type 2002-2010
• Figure 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery by Type 2002-2010
• Table 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2002-2010
• Figure 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2006
• Figure 4-4: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2010
• Table 4-4: Worldwide Market for Injectable/Implantable Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
• Table 4-5: Injectable/Implantable Drug Delivery Systems: Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
• Figure 4-5: Injectable/Implantable Drug Delivery Systems Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
• Figure 4-6: Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010

chapter five: Competitive and Market Analysis

• Table 5-1: Leading Suppliers of Injectable/Implantable Drug Delivery Technology
• Figure 5-1: Cost per Million Injections by Injector Type